Resources Contact Us Home
Modified factor VIII

Image Number 8 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Storage device performance alignment notification
Method and apparatus for predicting object properties and events using similarity-based information retrieval and modeling
Pressure-sensitive adhesive composition for optical films, pressure-sensitive adhesive optical film and image display
System and method for providing location and access network information support in a network environment
Antibody recognizing turn structure in amyloid .beta.
Controller interface providing improved data reliability
Keypoint descriptor generation by complex wavelet analysis
  Randomly Featured Patents
Combination energy absorbing foundation
Weed stick spray
Profile measuring of tube/pipe ends
Liquid crystal display panel and liquid crystal display device incorporating the same
Self-bonding one-component dimedone RTV silicone rubber compositions
Patterning system for a selected body type and methods of measuring for a selected body type
Vane pump
Punching tool for taking biological samples
Log supporting rack for use in a fireplace
Interferon-alpha polypeptides and conjugates